Adavivint (SM04690) is a Wnt pathway inhibitor being developed by Samumed for immunomodulatory potential. It is example 10 claimed in patent US20160297812 [2
]. The chemical structure shown here was produced using the IUPAC name submitted to the WHO for the proposed INN adavivint (via
SMILES generated using Chemicalize). This SMILES string resolves to PubChem CID 123710737, although some of the double bonds in the molecule are not fully resolved, when compared to the images in US20160297812. CID 89837869
is an alternative representation.